江门市生物医药(健康)产业发展中的政府作用探析
发布时间:2018-06-15 10:53
本文选题:地方政府 + 生物医药 ; 参考:《兰州大学》2013年硕士论文
【摘要】:21世纪进入生物技术的世纪,基因操作技术、基因芯片技术、蛋白质技术、生物医学工程技术、生物信息技术、超临界二氧化碳萃取技术、膜分离技术等生物技术已广泛地应用于医疗、农业、资源开发、环境保护及制药工业之中,其中最活跃的应用领域就是生物医药(健康)产业;健康产业是一种有巨大市场潜力的新兴产业,目前涉及医药产品、保健用品、营养食品、医疗器械、休闲健身、健康管理、健康咨询等多个与人类健康紧密相关的生产和服务领域。因此,生物医药(健康)产业被投资者普遍视为成长性最好的产业之一 生物技术创新、科研成果的产业化开发是一个系统工程,要靠有效的政策来整合。生物医药产业是知识创新(应用基础研究)、技术创新(应用开发)、成果转化、规模化生产各个环节的整合,而这些环节都不是一个机构完成的,任何一个机构,包括作为产业化主体的企业,不可能起这种系统整合的作用,必须发挥政府的组织协调功能,建立促进生物产业快速发展的机制和政策环境,充分发挥企业作为生物产业发展主体作用,加快生物技术的发展并快速实现产业化。 目前,江门市生物医药(健康)产业发展正处于高速发展期,江门市生物医药(健康)产业整体保持20%以上的速度发展。未来中国生物医药(健康)产业也将迎来加速发展和布局调整的重要机遇。作为珠江三角洲城市之一,江门在区域和历史上形成的地位优越性,和全国的生物医药(健康)产业相比,既要竞争,又要相互促进,理清江门的生物医药(健康)产业发展思路,不仅能带动泛珠三角区域的生物医药(健康)产业发展,对全国的生物医药(健康)产业也有一定的促进作用。 本文试图以江门市生物医药(健康)产业发展为例,在分析国际、国内和广东省生物医药(健康)产业分布特点、资源特征和发展趋势的基础上,对江门市生物医药(健康)产业未来的空间发展趋势进行分析,通过理论基础分析,从多角度,多方面提出江门市生物医药(健康)产业发展思路,以期为实现公共部门在地方产业发展中合理的定位,提高政府部门公共服务质量与效率提供有益的尝试。
[Abstract]:Into the 21st century biotechnology, gene manipulation technology, gene chip technology, protein technology, biomedical engineering technology, biological information technology, supercritical carbon dioxide extraction technology, Membrane separation technology has been widely used in medical treatment, agriculture, resource development, environmental protection and pharmaceutical industry, among which the most active application field is biomedicine (health) industry. The health industry is a new industry with great market potential. At present, it involves medical products, health products, nutritious foods, medical devices, leisure and fitness, and health management. Health consultation and other areas of production and services closely related to human health. Therefore, biopharmaceutical (health) industry is generally regarded by investors as one of the best growing industries in biotechnology innovation. The industrialization development of scientific research results is a system engineering, which must be integrated by effective policies. The biomedical industry is the integration of all aspects of knowledge innovation (applied basic research, technological innovation, application development, achievement transformation, large-scale production), and none of these links are completed by one organization, any one institution. Including the enterprises as the main body of industrialization, it is impossible for them to play the role of system integration. They must give play to the function of government organization and coordination, and establish the mechanism and policy environment to promote the rapid development of biological industry. Give full play to the role of enterprises as the main body of biological industry development, accelerate the development of biotechnology and realize industrialization quickly. At present, the development of Jiangmen Biopharmaceutical (Health) Industry is in a period of rapid development, and Jiangmen Biopharmaceutical (Health) Industry as a whole maintains a speed of more than 20%. In the future, China's biomedical (health) industry will also usher in an important opportunity for accelerated development and layout adjustment. As one of the cities in the Pearl River Delta, Jiangmen's superiority in regional and historical status, compared with the biomedical (health) industry in the whole country, should not only compete but also promote each other. To clarify the development of the biomedical (health) industry in Jiangmen can not only promote the development of the biomedical (health) industry in the Pan-Pearl River Delta region, but also promote the biomedical (health) industry in the whole country. Taking the development of biomedical (health) industry in Jiangmen City as an example, this paper attempts to analyze the distribution characteristics, resource characteristics and development trend of biomedical (health) industry in international, domestic and Guangdong provinces. This paper analyzes the future spatial development trend of the biological medicine (health) industry in Jiangmen city, and puts forward the ideas of the development of the biological medicine (health) industry in Jiangmen city from many angles and many aspects through the theoretical basis analysis. In order to realize the reasonable position of public sector in the development of local industry and improve the quality and efficiency of public service of government departments.
【学位授予单位】:兰州大学
【学位级别】:硕士
【学位授予年份】:2013
【分类号】:F426.72
【参考文献】
相关期刊论文 前10条
1 陆广新;;生物技术在制药领域中的应用及生物医药现状分析[J];安徽科技;2006年04期
2 王凯峰;;公共政策的理论与现实——从公共政策的基础理论看公共政策冲突[J];滨州学院学报;2008年04期
3 陈耀东;莫力根;;中国乳都——呼和浩特[J];中国城市经济;2006年01期
4 凌捷;;后金融危机时代南宁生物医药产业的培育和发展研究——以南宁高新区为例[J];改革与战略;2011年01期
5 于丽英;;我国生物医药产业的集聚态势及其效应的实证分析[J];工业技术经济;2009年09期
6 李志军;;加快生物产业发展步伐[J];中国创业投资与高科技;2006年02期
7 雷利芳;;我国生物制药业发展之我见[J];海峡药学;2007年01期
8 林昌华;;政府推动县域产业转型升级路径研究——对“福建晋江经验”的探索[J];金融经济;2011年18期
9 陈志平;;产业集群发展中的政府作用:理论与实证分析[J];吉首大学学报(社会科学版);2007年03期
10 鲁汇;龚峰;;湖北省生物医药产业SWOT分析及发展策略研究[J];科技管理研究;2010年21期
,本文编号:2021764
本文链接:https://www.wllwen.com/guanlilunwen/shengchanguanlilunwen/2021764.html